A core formulation

Details for Australian Patent Application No. 2001273310 (hide)

Owner Aeropharm Technology Incorporated

Inventors Adjei, Akwete L.; Zhu, Yaping; Cutie, Anthony J.

Agent Paul F Kildea

Pub. Number AU-B-2001273310

PCT Pub. Number WO2003/005991

Filing date 10 July 2001

Wipo publication date 29 January 2003

Acceptance publication date 7 October 2004

International Classifications

A61K 009/16 Medicinal preparations characterised by special physical form - Agglomerates

Event Publications

22 May 2003 Application Open to Public Inspection

  Published as AU-B-2001273310

7 October 2004 Application Accepted

  Published as AU-B-2001273310

18 November 2004 Assignment before Grant

  Aeropharm Technology, Inc. The application has been assigned to Kos Life Sciences, Inc. 2002

10 February 2005 Standard Patent Sealed

22 February 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001273311-Post assembly metallization of a device

2001273309-CORE FORMULATION COMPRISING TROGLITAZONE AND A BIGUANIDE